Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Apr 30:10:908.
doi: 10.3389/fimmu.2019.00908. eCollection 2019.

Immunopathogenesis of Pediatric Localized Scleroderma

Affiliations
Review

Immunopathogenesis of Pediatric Localized Scleroderma

Kathryn S Torok et al. Front Immunol. .

Abstract

Localized scleroderma (LS) is a complex disease characterized by a mixture of inflammation and fibrosis of the skin that, especially in the pediatric population, also affects extracutaneous tissues ranging from muscle to the central nervous system. Although developmental origins have been hypothesized, evidence points to LS as a systemic autoimmune disorder, as there is a strong correlation to family history of autoimmune disease, the presence of shared HLA types with rheumatoid arthritis, high frequency of auto-antibodies, and elevated circulating chemokines and cytokines associated with T-helper cell, IFNγ, and other inflammatory pathways. This inflammatory phenotype of the peripheral blood is reflected in the skin via microarray, RNA Sequencing and tissue staining. Research is underway to identify the key players in the pathogenesis of LS, but close approximation of inflammatory lymphocytic and macrophage infiltrate with collagen and fibroblasts deposition supports the notion that LS is a disease of inflammatory driven fibrosis. The immune system is dynamic and undergoes changes during childhood, and we speculate on how the unique features of the immune system in childhood could potentially contribute to some of the differences in LS between children and adults. Interestingly, the immune phenotype in pediatric LS resembles to some extent the healthy adult cellular phenotype, possibly supporting accelerated maturation of the immune system in LS. We discuss future directions in better understanding the pathophysiology of and how to better treat pediatric LS.

Keywords: autoimmune disease; disease etiology; fibrosis; immunophenotype; localized scleroderma; morphea; pediatric rheumatology; skin.

PubMed Disclaimer

Figures

Figure 1
Figure 1
(Left) Swirling lines of Blaschko on patient's right trunk with pediatric-onset localized scleroderma. Note several other patches of morphea on trunk and axilla. She also had linear bands of fibrosis traveling down posterior aspects of bilateral arms and right greater than left leg following lines of Blaschko. Written informed consent was obtained for the clinical photograph. (Right) Diagram of lines of Blaschko. Without modification from Tenea (33).
Figure 2
Figure 2
Proposed cellular interactions of macrophages, fibroblasts, and T cells in localized scleroderma. Resident macrophages stimulate T cells and fibroblasts via TH1/IFNγ associated cytokine network to produce inflammation and collagen accumulation in the skin.

Similar articles

Cited by

References

    1. Mayes MD, Lacey JVJr, Beebe-Dimmer J, Gillespie BW, Cooper B, Laing TJ, et al. Prevalence, incidence, survival, and disease characteristics of systemic sclerosis in a large US population. Arthritis Rheum. (2003) 48:2246–55. 10.1002/art.11073 - DOI - PubMed
    1. Peterson L, Nelson A, Su W, Mason T, O'Fallon W, Gabriel S. The epidemiology of morphea (localized scleroderma) in Olmstead County 1960–1993. J Rheumatol. (1997) 24:73–80. - PubMed
    1. Scalapino K, Arkaschaisri T, Lucas M, Fertig N, Helfrich D, Londino AJ, et al. Childhood onset systemic sclerosis: classification, clinical and serologic features, and survival in comparison with adult onset disease. J Rheumatol. (2006) 33:1004–13. - PubMed
    1. Li SC. Scleroderma in children and adolescents: localized scleroderma and systemic sclerosis. Pediatr Clin North Am. (2018) 65:757–81. 10.1016/j.pcl.2018.04.002 - DOI - PubMed
    1. Guevara-Gutierrez E, Yinh-Lao J, Garcia-Gutierrez P, Tlacuilo-Parra A. Frequency of antinuclear antibodies in mestizo Mexican children with morphea. Clin. Rheumatol. (2010) 29:1055–9. 10.1007/s10067-010-1515-2 - DOI - PubMed

Publication types